Scholar Rock claims that his experimental drug for spinal muscular atrophy can accomplish what not one of the at the moment obtainable therapies can do to deal with this uncommon illness. After constructive knowledge from a pivotal examine despatched biotech shares skyrocketing, Scholar Rock has raised $300 million in an fairness providing that will likely be used for regulatory submissions […]